首页> 美国政府科技报告 >Realizing the Translational Potential of Telomere Length Variation as a Tissue- Based Prognostic Marker for Prostate Cancer.

【24h】

Realizing the Translational Potential of Telomere Length Variation as a Tissue- Based Prognostic Marker for Prostate Cancer.

机译：实现端粒长度变异的转化潜能作为基于组织的前列腺癌预后标志物。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
页码 1-10
总页数 10
原文格式 PDF
正文语种 eng
中图分类
关键词
Prostate cancer;

机译：前列腺癌;

相似文献

外文文献
中文文献
专利

1. 基于上皮-间质转化标志物的循环肿瘤细胞表型检测对HER2阴性转移性乳腺癌一线化疗的预后意义 [J] . Xiuwen Guan, Ruigang Cai, Ying Fan, 癌症（英文版） . 2019,第009期
2. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death [J] . HeaphyC.M., YoonG.S., PeskoeS.B., Cancer discovery. . 2013,第10期

机译：前列腺癌细胞端粒长度变异和基质细胞端粒长度是转移和死亡的预后标志
3. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer. [J] . Ghadersohi A, Sharma S, Zhang S, The Prostate . 2011,第11期

机译：前列腺来源的Ets转录因子（PDEF）是前列腺癌患者的潜在预后标志物。
4. Re: Rano Matta, Christopher JD Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3-7 Translational Potential of Dual Detection: Depression Diagnosis plus Sense of Coherence Determination in Prostate Cancer [J] . Vale Salvador European urology . 2019,第6期

机译：Re：Rano Matta，Christopher Jd Wallis，Mitchell G. Goldenberg等。抗抑郁症抗抑郁症治疗非容性前列腺癌的抗抑郁症的变异与趋势：一种基于人群的群组研究。 2019年EUR UROL; 75：3-7双重检测的翻译潜力：抑郁症诊断加上前列腺癌的相干性测定感
5. CO-OCCURRENCE FEATURES CHARACTERIZING GLAND DISTRIBUTION PATTERNS AS NEW PROGNOSTIC MARKERS IN PROSTATE CANCER WHOLE-SLIDE IMAGES [C] . N. Harder, M. Athelogou, H. Hessel, IEEE International Symposium on Biomedical Imaging . 2016

机译：共同发生特征将腺体分布模式表征为前列腺癌全幻灯片的新预后标志物
6. Telomere DNA content andhTERTmRNA levels are novel prognostic markers in breast and prostate cancer. [D] . Fordyce, Colleen Augusta. 2002

机译：端粒DNA含量和hTERTmRNA水平是乳腺癌和前列腺癌的新的预后标志物。
7. Prostate Cancer Cell Telomere Length Variability and Stromal Cell Telomere Length as Prognostic Markers for Metastasis and Death [O] . Christopher M. Heaphy, Ghil Suk Yoon, Sarah B. Peskoe, -1

机译：前列腺癌细胞端粒长度变异和间质细胞端粒长度作为转移和死亡的预后标志
8. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population-based consecutive cases [O] . Jan-Erik Johansson, Theodor Sigurdsson, Lars Holmberg, 1992

机译：红细胞沉积率作为人类前列腺癌中的肿瘤标志物。 300名人口连续案例预后因素分析
9. Realizing the Translational Potential of Telomere Length Variation as a Tissue Based Prognostic Marker for Prostate Cancer. [R] . Platz, E. A. 2016

机译：实现端粒长度变异的转化潜能作为基于组织的前列腺癌预后标志物。

Realizing the Translational Potential of Telomere Length Variation as a Tissue- Based Prognostic Marker for Prostate Cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅